To select the promoter region that differentiates between controls and patients and to design the ddPCR primers, we took into consideration previous reports on SHOX2 methylation in NSCLC that were conducted with other analytical methods [15,17]. Here, SHOX2 is linked to non-small cell lung carcinoma.